|
Delayed
Börse Stuttgart
18:18:15 25/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 34.30 EUR | +0.18% |
|
-2.12% | +36.96% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-12 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.13x | 4.78x | 2.55x | 6.4x | 22.2x | 26.88x | 0.92% | 46.24B | |
| 15.79x | 1.76x | 7.56x | 1.95x | 8.67x | 11x | 1.71% | 36.48B | |
| 28.3x | 3.9x | -1.69x | 4.03x | 16.71x | 23.39x | 0.57% | 12.27B | |
| 27.23x | 3.01x | 3.88x | 3.3x | 17.12x | 21.97x | 0.93% | 11.77B | |
| 18.58x | 3.38x | 3.15x | 3.37x | 11.75x | 13.98x | 3.79% | 8.95B | |
| 29.56x | 5.43x | 0.42x | 3.87x | 17.99x | 21.68x | 0.16% | 7.14B | |
| 9.31x | 1.53x | 1.34x | 2.15x | 5.56x | 6.77x | 4.77% | 7.16B | |
| 15.29x | 1.28x | 2.54x | 2.03x | 6.73x | 9.55x | 3.25% | 7.12B | |
| 35.3x | 8.16x | 1.89x | 6.88x | 25.17x | 27.79x | 0.99% | 4.61B | |
| 16.11x | 0.79x | -0.03x | 2.21x | 9.48x | 11.99x | 1.68% | 4.28B | |
| 15.87x | 2.81x | -9.45x | 3.21x | 12.08x | 14.41x | 3.07% | 2.77B | |
| 18.76x | 4.76x | 4.22x | 5.34x | 16.01x | 17.52x | 3.22% | 2.42B | |
| 13.14x | - | -0.86x | 9.19x | 9.02x | 9.3x | - | 2.31B | |
| 28.62x | - | -0.11x | - | - | - | - | 2.22B | |
| 29.98x | 4.93x | 2.19x | - | - | - | - | 2.27B | |
| Average | 22.40x | 3.58x | 1.17x | 4.15x | 13.73x | 16.63x | 2.09% | 10.53B | |
| Weighted average by Cap. | 24.41x | 3.45x | 2.99x | 4.09x | 15.11x | 18.69x | 1.61% |
- Stock Market
- Stocks
- RICHTER Stock
- RIG2 Stock
- Sector Gedeon Richter
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
